Dear Mister/Madame,
having being invited to present a proposal for the EU-funded project for
Nicaragua 'Fortalecimiento del sistema de salud (NIC/B7-310/96/88)', we are
looking for a possible expert in drugs.
We are a 3 member consortium, led by the French company SODETEG and also
composed by the Italian company COTECNO srl and the Swedish company
Indevelop.
It is required:
- EU nationality;
- proficiency in Spanish;
- degree in pharmacology and/or in chemical engineering (or equivalent);
- 5 year-experience in commercial policy for drugs and/or quality control
and registration of drugs.
He will be encharged to work in Nicaragua for 20 months as a member of a
technical assistance team of European experts to support the Ministry of
Health and in particular:
- to study the list of drugs in collaboration with the national
universities and to support the 'Divisi�n de Farmacia' for the revision of
the list of registered drugs;
- to study the quality of the registered drugs and to support the
'Laboratorio Nacional de Control de Calidad' in defining a quality control
system for drugs;
- to collaborate in the formulation of a law for ensuring the control on
the bio-equivalence s;
- to study the drugs market and to formulate proposal for the free
circulation of drugs.
If you need some additional information and/or if you have the required
profile, please do not hesitate to contact Mrs. Rozenn Le Roux Mion (E.mail
address rozenn.le-roux-mion@sodeteg.thomson.fr)and/or Mrs. Maria Teresa
Mamm� (E.mail address: cotecno@compuserve.com).
In any case, please take note that this request is very urgent because we
have to submit our proposal by next friday and it will be no possible to
take into consideration any candidature presented after this date.
Thanking you for your attention, I remain
Yours sincerely
COTECNO Srl
Lucilla Di Virgilio
(Research and Development)
Email: valerio.DV@email.telpress.it
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.